Use Options For a Chance To Buy VRX at a 43% Discount

Looking back to 133 days ago, Valeant Pharmaceuticals International Inc (VRX) priced a 7,286,432 share secondary stock offering at $199.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 28.5% above the offering price..